Bank of New York Mellon Corp - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 40 filers reported holding LUMOS PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$39,1300.0%11,8580.0%0.00%
Q2 2023$39,130
-0.3%
11,8580.0%0.00%
Q1 2023$39,248
-8.3%
11,8580.0%0.00%
Q4 2022$42,806
-59.2%
11,8580.0%0.00%
Q3 2022$105,000
+15.4%
11,8580.0%0.00%
Q2 2022$91,000
-18.0%
11,858
+0.0%
0.00%
Q1 2022$111,000
+33.7%
11,8570.0%0.00%
Q4 2021$83,000
-25.9%
11,8570.0%0.00%
Q3 2021$112,000
-29.6%
11,857
-25.7%
0.00%
Q2 2021$159,000
-18.9%
15,961
-4.5%
0.00%
Q1 2021$196,000
-68.6%
16,709
-4.5%
0.00%
Q4 2020$625,00017,4930.00%
Other shareholders
LUMOS PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders